Joshua McClure 7/1/21 Joshua McClure 7/1/21 Turning Nature’s Virus Fighters Into Powerful Drugs: Synthetic “Peptoids” to Cure Diseases Read More Guest User 6/7/21 Guest User 6/7/21 ViewPoints Interview: Maxwell Biosciences’ Dr. Gill Diamond and Joshua McClure Share Insights Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2 Read More Guest User 6/1/21 Guest User 6/1/21 Stanford Engineering magazine profiles Dr. Annelise Barron: A bioengineer aims to turn nature's virus into powerful drugs Read More Guest User 5/18/21 Guest User 5/18/21 Maxwell Biosciences Announces the CLAROMER® Brand Biotech Therapeutics Platform as It Advances Toward Clinical Trials Read More Guest User 4/7/21 Guest User 4/7/21 David Evans Shaw Invests in Maxwell Biosciences to Advance the New Class of Antiviral Drugs Read More Guest User 4/5/21 Guest User 4/5/21 New research published in Pharmaceuticals (MDPI) demonstrates that several peptoids exhibit potent in vitro antiviral activity against both HSV-1 and SARS-CoV-2 Read More Guest User 3/23/21 Guest User 3/23/21 NPR Webcast featuring Maxwell Biosciences Chief Scientific Officer: Science, Rhetoric and Society Read More Guest User 3/10/21 Guest User 3/10/21 MEDIA ADVISORY:Maxwell Biosciences to Present at the Upcoming 2021 Spring Private Company Showcase Hosted by Credit Suisse, Solebury Trout, and Cooley Read More Guest User 3/3/21 Guest User 3/3/21 Maxwell Biosciences Appoints Kent Kirshenbaum, Ph.D. as Chief Scientific Officer and Sheetal Vali, Ph.D. as Director of Drug Development Read More Joshua McClure 6/11/19 Joshua McClure 6/11/19 Maxwell Focus: Next Generation Anti-infectives Read More Newer Posts
Joshua McClure 7/1/21 Joshua McClure 7/1/21 Turning Nature’s Virus Fighters Into Powerful Drugs: Synthetic “Peptoids” to Cure Diseases Read More
Guest User 6/7/21 Guest User 6/7/21 ViewPoints Interview: Maxwell Biosciences’ Dr. Gill Diamond and Joshua McClure Share Insights Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2 Read More
Guest User 6/1/21 Guest User 6/1/21 Stanford Engineering magazine profiles Dr. Annelise Barron: A bioengineer aims to turn nature's virus into powerful drugs Read More
Guest User 5/18/21 Guest User 5/18/21 Maxwell Biosciences Announces the CLAROMER® Brand Biotech Therapeutics Platform as It Advances Toward Clinical Trials Read More
Guest User 4/7/21 Guest User 4/7/21 David Evans Shaw Invests in Maxwell Biosciences to Advance the New Class of Antiviral Drugs Read More
Guest User 4/5/21 Guest User 4/5/21 New research published in Pharmaceuticals (MDPI) demonstrates that several peptoids exhibit potent in vitro antiviral activity against both HSV-1 and SARS-CoV-2 Read More
Guest User 3/23/21 Guest User 3/23/21 NPR Webcast featuring Maxwell Biosciences Chief Scientific Officer: Science, Rhetoric and Society Read More
Guest User 3/10/21 Guest User 3/10/21 MEDIA ADVISORY:Maxwell Biosciences to Present at the Upcoming 2021 Spring Private Company Showcase Hosted by Credit Suisse, Solebury Trout, and Cooley Read More
Guest User 3/3/21 Guest User 3/3/21 Maxwell Biosciences Appoints Kent Kirshenbaum, Ph.D. as Chief Scientific Officer and Sheetal Vali, Ph.D. as Director of Drug Development Read More
Joshua McClure 6/11/19 Joshua McClure 6/11/19 Maxwell Focus: Next Generation Anti-infectives Read More
